Table 3. Age-standardised estimates of 1- and 5-year net survival by cancer, stage, and staging strategy.
| Non-restrictive staging strategy | Restrictive staging strategy | |
|---|---|---|
| Stage | NS (CI) | NS (CI) |
|
Colorectal cancer | ||
| One-year net survival | ||
| I | 0.979 (0.976, 0.981) | 0.982 (0.978, 0.985) |
| II | 0.936 (0.933, 0.939) | 0.949 (0.945, 0.952) |
| III | 0.880 (0.877, 0.883) | 0.898 (0.893, 0.902) |
| IV | 0.495 (0.489, 0.501) | 0.510 (0.504, 0.515) |
| Missing | 0.605 (0.599, 0.612) | 0.777 (0.774, 0.780) |
| Five-year net survival | ||
| I | 0.952 (0.944, 0.960) | 0.957 (0.945, 0.969) |
| II | 0.849 (0.843, 0.855) | 0.861 (0.852, 0.871) |
| III | 0.638 (0.632, 0.645) | 0.665 (0.655, 0.674) |
| IV | 0.152 (0.146, 0.157) | 0.158 (0.152, 0.164) |
| Missing | 0.414 (0.406, 0.423) | 0.619 (0.614, 0.624) |
|
Lung cancer | ||
| One-year net survival | ||
| I | 0.843 (0.837, 0.848) | 0.852 (0.846, 0.858) |
| II | 0.685 (0.675, 0.695) | 0.693 (0.683, 0.704) |
| III | 0.431 (0.425, 0.437) | 0.439 (0.433, 0.445) |
| IV | 0.182 (0.179, 0.185) | 0.183 (0.180, 0.186) |
| Missing | 0.256 (0.250, 0.262) | 0.298 (0.293, 0.303) |
| Five-year net survival | ||
| I | 0.542 (0.531, 0.554) | 0.541 (0.529, 0.554) |
| II | 0.325 (0.310, 0.340) | 0.325 (0.309, 0.341) |
| III | 0.099 (0.094, 0.104) | 0.100 (0.095, 0.105) |
| IV | 0.025 (0.024, 0.027) | 0.026 (0.024, 0.028) |
| Missing | 0.093 (0.088, 0.098) | 0.125 (0.120, 0.130) |
Abbreviations: CI, confidence interval; NS, net survival. Diagnoses in England, 2008–2012.